Biotechnology (32) | Transition Agreements (32)

Browse by Company

Recent Contracts

Employment Transition Agreement between Frank Hsu, M.D. and Registrant, dated February 24, 2021 (GTX INC, Filed With SEC on May 6, 2021)
Transition Agreement, dated March 31, 2021, by and between Allena Pharmaceuticals, Inc. and Edward Wholihan (Allena Pharmaceuticals, Inc., Filed With SEC on April 2, 2021)
Transition Agreement, dated November 17, 2020, by and between Sheila Gujrathi, M.D. and the Registrant (Gossamer Bio, Inc., Filed With SEC on February 26, 2021)
Transition and CEO Support Agreement, dated February 9, 2020, by and between J. Jeffrey Goater and Surface Oncology, Inc (Surface Oncology, Inc., Filed With SEC on February 11, 2021)
Amendment No. 2 dated October 8, 2020 to the Transition Letter Agreement between Shalini Sharp and Ultragenyx Pharmaceutical Inc. dated as of March 5, 2020, as amended on August... (Ultragenyx Pharmaceutical Inc., Filed With SEC on October 13, 2020)
Transition Services Agreement, dated as of September 30, 2020, between PDL BioPharma, Inc. and LENSAR, Inc (PDL BIOPHARMA, INC., Filed With SEC on October 2, 2020)
Transition Agreement, dated as of September 25, 2020, between the Company and Christopher B. Primiano (Karyopharm Therapeutics Inc., Filed With SEC on September 25, 2020)
Amendment dated as of August 28, 2020 to Transition Letter Agreement between Shalini Sharp and Ultragenyx Pharmaceutical Inc. dated as of March 5, 2020 (Ultragenyx Pharmaceutical Inc., Filed With SEC on September 2, 2020)
Transition Agreement and Release, dated June 25, 2020, between Selecta Biosciences, Inc. and Stephen Smolinski (SELECTA BIOSCIENCES INC, Filed With SEC on June 25, 2020)
Transition Agreement and Release, dated June 25, 2020, between Selecta Biosciences, Inc. and Elona Kogan (SELECTA BIOSCIENCES INC, Filed With SEC on June 25, 2020)